Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide compassionate use of anecortave acetate sterile
suspension of 15 mg for a series of five patients as a means to control pseudovitelliform
detachment.